View Financial HealthMegaMD 배당 및 자사주 매입배당 기준 점검 3/6MegaMD 수익으로 충분히 충당되는 현재 수익률 3.97% 보유한 배당금 지급 회사입니다.핵심 정보4.0%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률6.8%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향42%최근 배당 및 자사주 매입 업데이트공시 • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).분석 기사 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).모든 업데이트 보기Recent updates공시 • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Korea공시 • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩42.2b market cap, or US$28.9m).Buy Or Sell Opportunity • Sep 10Now 21% overvaluedOver the last 90 days, the stock has fallen 11% to ₩2,005. The fair value is estimated to be ₩1,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Earnings per share has grown by 11%.New Risk • May 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩46.4b market cap, or US$33.3m).New Risk • Apr 10New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₩56.8b market cap, or US$38.9m).분석 기사 • Apr 08MegaMD Co., Ltd.'s (KOSDAQ:133750) 27% Price Boost Is Out Of Tune With RevenuesThe MegaMD Co., Ltd. ( KOSDAQ:133750 ) share price has done very well over the last month, posting an excellent gain of...Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩2,435, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 10x in the Consumer Services industry in South Korea. Total loss to shareholders of 33% over the past three years.분석 기사 • Mar 28MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong FactorsMegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...New Risk • Mar 28New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩47.4b market cap, or US$32.3m).공시 • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South KoreaValuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₩2,425, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 50% over the past three years.분석 기사 • Nov 13MegaMD (KOSDAQ:133750) Is Looking To Continue Growing Its Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Valuation Update With 7 Day Price Move • Aug 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩2,080, the stock trades at a trailing P/E ratio of 36.2x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 57% over the past three years.Buy Or Sell Opportunity • Aug 16Now 28% overvaluedOver the last 90 days, the stock has fallen 6.9% to ₩2,440. The fair value is estimated to be ₩1,900, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.분석 기사 • Aug 08A Look At The Intrinsic Value Of MegaMD Co., Ltd. (KOSDAQ:133750)Key Insights Using the 2 Stage Free Cash Flow to Equity, MegaMD fair value estimate is ₩1,874 MegaMD's ₩1,908 share...Buy Or Sell Opportunity • Jul 08Now 26% overvaluedOver the last 90 days, the stock has fallen 13% to ₩2,155. The fair value is estimated to be ₩1,711, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.분석 기사 • Apr 18Some MegaMD Co., Ltd. (KOSDAQ:133750) Shareholders Look For Exit As Shares Take 25% PoundingMegaMD Co., Ltd. ( KOSDAQ:133750 ) shareholders won't be pleased to see that the share price has had a very rough...분석 기사 • Feb 26MegaMD Co., Ltd.'s (KOSDAQ:133750) Popularity With Investors Is Under Threat From OverpricingWhen close to half the companies in the Consumer Services industry in Korea have price-to-sales ratios (or "P/S") below...New Risk • Nov 27New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩61.4b market cap, or US$47.1m).New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩56.1b market cap, or US$43.0m).Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).Buying Opportunity • Aug 22Now 20% undervaluedOver the last 90 days, the stock is up 16%. The fair value is estimated to be ₩4,661, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable.Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₩4,130, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 135% over the past three years.Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₩3,590, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total returns to shareholders of 87% over the past three years.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,785, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 35% over the past three years.Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩4,445, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Consumer Services industry in South Korea. Total returns to shareholders of 99% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩151 (vs ₩117 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩20.1b (down 6.3% from 3Q 2020). Net income: ₩3.34b (up 31% from 3Q 2020). Profit margin: 17% (up from 12% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,200, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 156% over the past three years.Valuation Update With 7 Day Price Move • Apr 15Investor sentiment improved over the past weekAfter last week's 37% share price gain to ₩5,870, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 139% over the past three years.분석 기사 • Apr 05Is MegaMD Co., Ltd. (KOSDAQ:133750) The Right Choice For A Smart Dividend Investor?Could MegaMD Co., Ltd. ( KOSDAQ:133750 ) be an attractive dividend share to own for the long haul? Investors are often...분석 기사 • Mar 09Is MegaMD Co., Ltd.'s (KOSDAQ:133750) Recent Price Movement Underpinned By Its Weak Fundamentals?MegaMD (KOSDAQ:133750) has had a rough three months with its share price down 11%. It seems that the market might have...분석 기사 • Feb 08MegaMD (KOSDAQ:133750) Shareholders Booked A 44% Gain In The Last Three YearsBy buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...Is New 90 Day High Low • Jan 28New 90-day low: ₩3,610The company is down 5.0% from its price of ₩3,785 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 4.0% over the same period.분석 기사 • Jan 14What Do The Returns On Capital At MegaMD (KOSDAQ:133750) Tell Us?If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...분석 기사 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).분석 기사 • Dec 08Is MegaMD Co., Ltd. (KOSDAQ:133750) A Great Dividend Stock?Today we'll take a closer look at MegaMD Co., Ltd. ( KOSDAQ:133750 ) from a dividend investor's perspective. Owning a...Valuation Update With 7 Day Price Move • Nov 18Market bids up stock over the past weekAfter last week's 26% share price gain to ₩4,610, the stock is trading at a trailing P/E ratio of 36x, up from the previous P/E ratio of 28.6x. This compares to an average P/E of 18x in the Consumer Services industry in South Korea. Total returns to shareholders over the past three years are 73%.분석 기사 • Nov 17Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: A133750 10년 미만 동안 배당금을 지급해 왔으며 이 기간 동안 지급액은 휘발성이었습니다.배당금 증가: A133750 의 배당금 지급이 증가했지만 회사는 7 년 동안만 배당금을 지급했습니다.배당 수익률 vs 시장MegaMD 배당 수익률 vs 시장A133750의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (A133750)4.0%시장 하위 25% (KR)1.1%시장 상위 25% (KR)4.0%업계 평균 (Consumer Services)6.7%분석가 예측 (A133750) (최대 3년)n/a주목할만한 배당금: A133750 의 배당금( 3.97% )은 KR 시장에서 배당금 지급자의 하위 25%( 1.07% )보다 높습니다.고배당: A133750 의 배당금( 3.97% )은 KR 시장( 3.97% )주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 42.2% )로 A133750 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 배당금 지급이 현금 흐름에 의해 충당되는지 판단하기 위해 A133750 의 현금 지급 비율을 계산하기에는 데이터가 부족합니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YKR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/31 07:22종가2026/05/29 00:00수익2025/06/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스MegaMD Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.
Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).
Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).
분석 기사 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).
공시 • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Korea
공시 • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.
New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩42.2b market cap, or US$28.9m).
Buy Or Sell Opportunity • Sep 10Now 21% overvaluedOver the last 90 days, the stock has fallen 11% to ₩2,005. The fair value is estimated to be ₩1,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Earnings per share has grown by 11%.
New Risk • May 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩46.4b market cap, or US$33.3m).
New Risk • Apr 10New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₩56.8b market cap, or US$38.9m).
분석 기사 • Apr 08MegaMD Co., Ltd.'s (KOSDAQ:133750) 27% Price Boost Is Out Of Tune With RevenuesThe MegaMD Co., Ltd. ( KOSDAQ:133750 ) share price has done very well over the last month, posting an excellent gain of...
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩2,435, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 10x in the Consumer Services industry in South Korea. Total loss to shareholders of 33% over the past three years.
분석 기사 • Mar 28MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong FactorsMegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...
New Risk • Mar 28New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩47.4b market cap, or US$32.3m).
공시 • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Korea
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₩2,425, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 50% over the past three years.
분석 기사 • Nov 13MegaMD (KOSDAQ:133750) Is Looking To Continue Growing Its Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩2,080, the stock trades at a trailing P/E ratio of 36.2x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 57% over the past three years.
Buy Or Sell Opportunity • Aug 16Now 28% overvaluedOver the last 90 days, the stock has fallen 6.9% to ₩2,440. The fair value is estimated to be ₩1,900, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.
분석 기사 • Aug 08A Look At The Intrinsic Value Of MegaMD Co., Ltd. (KOSDAQ:133750)Key Insights Using the 2 Stage Free Cash Flow to Equity, MegaMD fair value estimate is ₩1,874 MegaMD's ₩1,908 share...
Buy Or Sell Opportunity • Jul 08Now 26% overvaluedOver the last 90 days, the stock has fallen 13% to ₩2,155. The fair value is estimated to be ₩1,711, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.
분석 기사 • Apr 18Some MegaMD Co., Ltd. (KOSDAQ:133750) Shareholders Look For Exit As Shares Take 25% PoundingMegaMD Co., Ltd. ( KOSDAQ:133750 ) shareholders won't be pleased to see that the share price has had a very rough...
분석 기사 • Feb 26MegaMD Co., Ltd.'s (KOSDAQ:133750) Popularity With Investors Is Under Threat From OverpricingWhen close to half the companies in the Consumer Services industry in Korea have price-to-sales ratios (or "P/S") below...
New Risk • Nov 27New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩61.4b market cap, or US$47.1m).
New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩56.1b market cap, or US$43.0m).
Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).
Buying Opportunity • Aug 22Now 20% undervaluedOver the last 90 days, the stock is up 16%. The fair value is estimated to be ₩4,661, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable.
Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₩4,130, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 135% over the past three years.
Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₩3,590, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total returns to shareholders of 87% over the past three years.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,785, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 35% over the past three years.
Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩4,445, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Consumer Services industry in South Korea. Total returns to shareholders of 99% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).
Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩151 (vs ₩117 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩20.1b (down 6.3% from 3Q 2020). Net income: ₩3.34b (up 31% from 3Q 2020). Profit margin: 17% (up from 12% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,200, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 156% over the past three years.
Valuation Update With 7 Day Price Move • Apr 15Investor sentiment improved over the past weekAfter last week's 37% share price gain to ₩5,870, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 139% over the past three years.
분석 기사 • Apr 05Is MegaMD Co., Ltd. (KOSDAQ:133750) The Right Choice For A Smart Dividend Investor?Could MegaMD Co., Ltd. ( KOSDAQ:133750 ) be an attractive dividend share to own for the long haul? Investors are often...
분석 기사 • Mar 09Is MegaMD Co., Ltd.'s (KOSDAQ:133750) Recent Price Movement Underpinned By Its Weak Fundamentals?MegaMD (KOSDAQ:133750) has had a rough three months with its share price down 11%. It seems that the market might have...
분석 기사 • Feb 08MegaMD (KOSDAQ:133750) Shareholders Booked A 44% Gain In The Last Three YearsBy buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...
Is New 90 Day High Low • Jan 28New 90-day low: ₩3,610The company is down 5.0% from its price of ₩3,785 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 4.0% over the same period.
분석 기사 • Jan 14What Do The Returns On Capital At MegaMD (KOSDAQ:133750) Tell Us?If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
분석 기사 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).
분석 기사 • Dec 08Is MegaMD Co., Ltd. (KOSDAQ:133750) A Great Dividend Stock?Today we'll take a closer look at MegaMD Co., Ltd. ( KOSDAQ:133750 ) from a dividend investor's perspective. Owning a...
Valuation Update With 7 Day Price Move • Nov 18Market bids up stock over the past weekAfter last week's 26% share price gain to ₩4,610, the stock is trading at a trailing P/E ratio of 36x, up from the previous P/E ratio of 28.6x. This compares to an average P/E of 18x in the Consumer Services industry in South Korea. Total returns to shareholders over the past three years are 73%.
분석 기사 • Nov 17Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...